Responses
Ovarian cancer
2022-RA-1387-ESGO Patients with minimal residual disease at upfront debulking surgery have similar survival outcome than patients with complete cytorreduction after neoadjuvant chemotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.